MX2023009445A - Compuestos de heterociclos tetraciclicos utiles como inhibidores de la integrasa del vih. - Google Patents
Compuestos de heterociclos tetraciclicos utiles como inhibidores de la integrasa del vih.Info
- Publication number
- MX2023009445A MX2023009445A MX2023009445A MX2023009445A MX2023009445A MX 2023009445 A MX2023009445 A MX 2023009445A MX 2023009445 A MX2023009445 A MX 2023009445A MX 2023009445 A MX2023009445 A MX 2023009445A MX 2023009445 A MX2023009445 A MX 2023009445A
- Authority
- MX
- Mexico
- Prior art keywords
- tetracyclic heterocycle
- heterocycle compounds
- compounds useful
- hiv integrase
- integrase inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163149927P | 2021-02-16 | 2021-02-16 | |
| PCT/US2022/016261 WO2022177840A1 (en) | 2021-02-16 | 2022-02-14 | Tetracyclic heterocycle compounds useful as hiv integrase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023009445A true MX2023009445A (es) | 2023-08-25 |
Family
ID=80625127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023009445A MX2023009445A (es) | 2021-02-16 | 2022-02-14 | Compuestos de heterociclos tetraciclicos utiles como inhibidores de la integrasa del vih. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11958864B2 (https=) |
| EP (1) | EP4294813B1 (https=) |
| JP (1) | JP2024507788A (https=) |
| KR (1) | KR20230147131A (https=) |
| CN (1) | CN117083282A (https=) |
| AR (1) | AR124868A1 (https=) |
| CA (1) | CA3208396A1 (https=) |
| ES (1) | ES3048138T3 (https=) |
| MX (1) | MX2023009445A (https=) |
| TW (1) | TW202246286A (https=) |
| WO (1) | WO2022177840A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY201239A (en) | 2019-03-22 | 2024-02-13 | Gilead Sciences Inc | Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use |
| PE20221569A1 (es) | 2020-02-24 | 2022-10-06 | Gilead Sciences Inc | Compuestos tetraciclicos para el tratamiento de infecciones por vih |
| ES3064867T3 (en) | 2020-09-30 | 2026-04-29 | Gilead Sciences Inc | Bridged tricyclic carbamoylpyridone compounds for a use in the treatment of hiv |
| US11613546B2 (en) | 2021-01-19 | 2023-03-28 | Gilead Sciences, Inc. | Substituted pyridotriazine compounds and uses thereof |
| TW202446773A (zh) | 2022-04-06 | 2024-12-01 | 美商基利科學股份有限公司 | 橋聯三環胺甲醯基吡啶酮化合物及其用途 |
| EP4704976A1 (en) * | 2023-04-28 | 2026-03-11 | Merck Sharp & Dohme LLC | Delivery devices for anti-hiv compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010011814A1 (en) * | 2008-07-25 | 2010-01-28 | Smithkline Beecham Corporation | Chemical compounds |
| JP5551697B2 (ja) * | 2008-07-25 | 2014-07-16 | ビーブ・ヘルスケア・カンパニー | 化合物 |
| ES2448766T3 (es) * | 2008-07-25 | 2014-03-17 | Viiv Healthcare Company | Profármacos de dolutegravir |
| DK2620436T3 (en) * | 2010-09-24 | 2018-07-30 | Shionogi & Co | Substituted polycyclic carbamoylpyridone derivative prodrug |
| WO2017113288A1 (en) * | 2015-12-31 | 2017-07-06 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors |
| JOP20190130A1 (ar) * | 2016-12-02 | 2019-06-02 | Merck Sharp & Dohme | مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv) |
| EP3573984A4 (en) * | 2017-01-26 | 2020-07-29 | Merck Sharp & Dohme Corp. | USEFUL SUBSTITUTE QUINOLIZINE DERIVATIVES AS HIV INTEGRASE INHIBITORS |
-
2022
- 2022-02-14 MX MX2023009445A patent/MX2023009445A/es unknown
- 2022-02-14 ES ES22707560T patent/ES3048138T3/es active Active
- 2022-02-14 US US17/670,689 patent/US11958864B2/en active Active
- 2022-02-14 EP EP22707560.3A patent/EP4294813B1/en active Active
- 2022-02-14 CN CN202280022034.3A patent/CN117083282A/zh active Pending
- 2022-02-14 TW TW111105302A patent/TW202246286A/zh unknown
- 2022-02-14 WO PCT/US2022/016261 patent/WO2022177840A1/en not_active Ceased
- 2022-02-14 CA CA3208396A patent/CA3208396A1/en active Pending
- 2022-02-14 JP JP2023548941A patent/JP2024507788A/ja active Pending
- 2022-02-14 KR KR1020237031339A patent/KR20230147131A/ko active Pending
- 2022-02-14 AR ARP220100289A patent/AR124868A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022223241A1 (en) | 2023-08-24 |
| EP4294813A1 (en) | 2023-12-27 |
| AR124868A1 (es) | 2023-05-10 |
| US20220259227A1 (en) | 2022-08-18 |
| KR20230147131A (ko) | 2023-10-20 |
| US11958864B2 (en) | 2024-04-16 |
| TW202246286A (zh) | 2022-12-01 |
| WO2022177840A1 (en) | 2022-08-25 |
| JP2024507788A (ja) | 2024-02-21 |
| ES3048138T3 (en) | 2025-12-09 |
| EP4294813B1 (en) | 2025-09-10 |
| CA3208396A1 (en) | 2022-08-25 |
| CN117083282A (zh) | 2023-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023009445A (es) | Compuestos de heterociclos tetraciclicos utiles como inhibidores de la integrasa del vih. | |
| DOP2019000140A (es) | Compuestos de heterociclo tetracíclicos útiles como inhibidores de la integrasa del vih | |
| DOP2023000168A (es) | Compuestos antivirales que contienen nitrilo | |
| UY37795A (es) | Sulfonilureas y sulfoniltioureas útiles como inhibidores de nlrp3 | |
| ECSP16016726A (es) | Derivados de quinolizina sustituidos útiles como inhibidores de integrasa del vih | |
| UY39032A (es) | Compuestos heterocíclicos como agentes antivirales | |
| MX2020011317A (es) | Compuestos heterociclicos triciclicos utiles como inhibidores de la integrasa de vih. | |
| UY38559A (es) | Inhibidores de la replicación del virus de la inmunodeficiencia humana | |
| UY38614A (es) | Derivados de benzodiazepinas como inhibidores del rsv | |
| MX2019006449A (es) | Compuestos heterociclicos triciclicos utiles como inhibidores de la integrasa del virus de inmunodeficiencia humana (vih). | |
| MX2012006297A (es) | Uso topico hidroxitirosol y derivados para la prevencion de la infeccion por vih. | |
| UY39642A (es) | Compuestos heterocíclicos antivirales | |
| AR127470A1 (es) | Inhibidores de lrrk2 | |
| CL2022002405A1 (es) | Inhibidores de la replicación del virus de inmunodeficiencia humana | |
| CO2025003090A2 (es) | Compuestos de piridinona sustituida como inhibidores de cbl-b | |
| MX2021009584A (es) | Nuevos derivados de triterpeno como inhibidores del virus de la inmunodeficiencia humana (vih). | |
| ECSP24007193A (es) | Compuestos pirimidínicos para usar como inhibidores de map4k1 | |
| UY40025A (es) | Derivados de naftiridinona para el tratamiento de una enfermedad o un trastorno, y composiciones far | |
| MX2025014666A (es) | Forma cristalina de sal sodica de derivados de piridona carbamoilica policiclica, su metodo de preparacion y aplicacion | |
| UY39738A (es) | Compuestos antivirales que contienen nitrilo | |
| ECSP23075535A (es) | Compuestos cíclicos y métodos de uso | |
| CL2022001935A1 (es) | Compuestos antivirales que contienen nitrilo | |
| AR118379A1 (es) | Derivados de benzodiazepinas como inhibidores del rsv |